Bridgepoint, one of the world’s leading mid-market investors,  announced that it has entered into an agreement to fully divest its investment in Evac, to Altor Equity Partners.

Evac is the global market leader in integrated water and waste management, corrosion protection, and marine growth prevention systems – mission-critical technologies that enable the world’s navies, cruise operators, and commercial fleets to operate safely, sustainably, and efficiently. Founded in 1979 and headquartered in Espoo, Finland, the company has a global installed base spanning tens of thousands of vessels and has a market-leading aftermarket offering. The company has delivered strong financial performance, with EBITDA set to reach c.€47 million in 2025 on the back of strong market activity and major naval spending programmes.

Under Bridgepoint’s ownership, Evac has broadened its product portfolio through a combination of in-house R&D and six strategic acquisitions, while significantly building out its aftermarket capabilities. This has reinforced its position as the industry’s most comprehensive full-suite provider, and enabled a shift towards a more recurring revenue model, with aftermarket and services now representing over two-thirds of total revenue. Evac’s evolution has drawn on Bridgepoint’s extensive sector expertise in scaling advanced industrial companies, and specifically environmental and water management services, including previous investments such as Miya Water and Ponant.

Björn Ullbro, CEO of Evac, said: “We have transformed Evac into a strong, efficient, and ambitious global player. This transaction marks the start of an exciting new chapter for Evac, and we look forward to working with Altor to accelerate our growth and deliver value to customers worldwide. The demand for sustainable solutions in our markets is accelerating at a pace we’ve never seen before. This momentum creates an exceptional opportunity for Evac to scale our innovations and deliver even greater value to customers worldwide.”

Patrick Fox, Senior Partner, and Christopher Bley, Partner and Co-Head of Nordics at Bridgepoint, said: “During our ownership, Evac has developed into a truly global leader with a differentiated portfolio and a highly resilient aftermarket business. Our targeted M&A programme has expanded capabilities in core niches, strengthened Evac’s global footprint, and created meaningful commercial synergies across the group. We are proud of the progress achieved together with the management team and believe the company is exceptionally well-positioned for its next phase of growth.”

Over the past 30 years, Bridgepoint has been committed to the Nordic region, having backed and supported nearly 30 platform investments. Evac marks the 4th successful exit in the last two years, having previously sold Diaverum in 2023 and partially exited Vitamin Well and Oris Dental in 2024. The transaction is expected to close in 2026, subject to customary regulatory approvals. Financial terms were not disclosed. Bridgepoint was advised by Citigroup Global Markets (M&A Advisor), EY (Financial, Tax, and Tech Due Diligence), Avance (Legal Advisor), and McKinsey (Commercial Due Diligence).